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Abstract
Background
Although most countries face increasing population levels of obesity and diabetes their
effect on coronary heart disease (CHD) mortality has not been often studied in small island
developing states (SIDs) where obesity rates are among the highest in the world. We esti-
mated the relative contributions of treatments and cardiovascular risk factors to the decline
in CHD mortality from 1990 to 2012 in the Caribbean island, Barbados.
Methods
We used the IMPACT CHD mortality model to estimate the effect of increased coverage of
effective medical/surgical treatments and changes in major CHD risk factors on mortality
trends in 2012 compared with 1990. We calculated deaths prevented or postponed (DPPs)
for each model risk factor and treatment group. We obtained data from WHO Mortality data-
base, population denominators from the Barbados Statistical Service stratified by 10-year
age group (ages 25–34 up to 85 plus), population-based risk factor surveys, Global Burden
of Disease and Barbados’ national myocardial infarction registry. Monte Carlo probabilistic
sensitivity analysis was performed.
Results
In 1990 the age-standardized CHD mortality rate was 109.5 per 100,000 falling to 55.3 in
2012. Implementation of effective treatment accounted for 56% DPPs (95% (Uncertainty
Interval (UI) 46%, 68%), mostly due to the introduction of treatments immediately after
acute myocardial infarction (AMI) (14%) and unstable angina (14%). Overall, risk factors
contributed 19% DPPs (95% UI 6% to 34%) mostly attributed to decline in cholesterol (18%
DPPs, 95% UI 12%, 26%). Adverse trends in diabetes: 14% additional deaths(ADs) 95% UI
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Conclusions
Given the significant negative impact of obesity/diabetes on mortality in this analysis,
research that explores factors affecting implementation of evidenced-based preventive
strategies is needed. The fact that most of the decline in CHD mortality in Barbados was
due to treatment provides an example for SIDs about the advantages of universal access to
care and treatment.
Introduction
Coronary heart disease (CHD) is the number one cause of death in the sub-region of the
Americas known as the Caribbean[1]. The Caribbean consists of 32 territories and small island
developing states (SIDS), approximately half of which are classified as lower and/or middle
income. Although most countries globally face increasing population levels of obesity, diabetes
and non-communicable diseases (NCDs), rates in SIDs are among the highest in the world[2–
4]. Many developed countries have been able to achieve decreases in CHD mortality over the
past three to four decades[5]. However, the picture is mixed among the nations of the Carib-
bean; countries such as St. Lucia, St. Vincent and Grenadines and Guyana have all recorded
increases in age adjusted CHD mortality, while Barbados and Trinidad and Tobago have
reported decreases over the period 1995 to 2008[6].
The factors underlying the differential rates and direction of change in CHD mortality
among countries in the Caribbean are not known. Broadly there are two categories of explana-
tion: differences in trends in the coverage of effective medical and surgical treatments and dif-
ferences in trends in risk factors. In the United States, for example, previous work has
suggested that around 47% of the decline in CHD mortality is attributable to improvements in
treatment and 44% to trends in risk factors[7].
The cardiovascular policy model, IMPACT, has been used in England, Finland, United
States and more recently in Syria and the West Bank to determine the proportion of change in
CHD mortality that is due to changes in risk factor and improvements in specific treatment[8–
10]. In this paper we seek to explain the trends in CHD mortality using the IMPACT model
for one Caribbean island (Barbados) for the period 1990–2012. Barbados, in addition to being
the location of several population-based surveys over the past decades, has the only active
Non-Communicable Disease (NCD) surveillance registry in the English-speaking Caribbean
and a recent population-based risk factor survey. The island was therefore chosen because of
ease of access to the data to populate the model, but with the intention that the process could
be used as an exemplar for other countries in the region. This is the first use of the model in a
predominantly African origin population.
Methods
Description of IMPACT
To explain the changes in cardiovascular mortality in Barbados between 1990 and 2012 we
used the IMPACT coronary heart disease (CHD) mortality model which has been applied pre-
viously applied in over 20 countries and validated against historical data in the United
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Kingdom. [8, 11–13]. The IMPACT model is used to estimate the number of CHD deaths pre-
vented or postponed by each specific cardiac intervention, or risk factor decline. It incorpo-
rates all major cardiovascular risk factors, including systolic blood pressure, mean cholesterol
concentration, diabetes, smoking, physical inactivity, overweight, and obesity, plus all standard
treatments for CHD and heart failure (S1 Table)[14]. The details of the methods of this model
have been explained previously[14]. Data in S1 and S2 Tables provide details of the coefficients
and relative risks used in the model. Here we present details relevant to the Barbados study.
Setting
Barbados is an island of 166 square miles and a population of 277 821 (according to 2010 cen-
sus data), comprising 92.4%, 2.7%, 3.1% and 1.8% who self-identify as black, white, mixed race
and other respectively(9). Barbados’ health care system is financed through general taxation
funds provided through government budgetary allocations. Health care services can be
obtained free at the point of delivery through a system of twelve outpatient primary care cen-
tres (polyclinics) and one 600 bed tertiary care facility. Citizens also have the option of paying
out-of-pocket or using private health insurance at various private primary care clinics.
Barbados has had a series of well-designed population-based studies providing sound data
for review and analysis. Studies such as the Barbados Eye Study (1989–1991)[15, 16], Study of
Health and Wellbeing of the Elderly (1999–2000)[17], the population-based Risk factor STEPS
Survey(2007) and Health of the Nation studies (2011–2013) [18] have been conducted. Barba-
dos is home to an active multi-disease register [19].
Population demographic changes and mortality
Information on population demographic changes, including numbers by 10-year age and sex
groups, was obtained from the Barbados Statistical Service (S3 Table). Data on deaths from
CHD were obtained from the mortality database of the World Health Organization (WHO)
which contained figures submitted by the local ministry through the Pan American Health
Organization (PAHO). For this model, we used data for persons aged 25 years and above.
Given the small population size in Barbados (277,668 in 2012 and 260,491 in 1990) and small
number (and thus inherent instability) of deaths per year from CHD, the number of deaths
entered the model was calculated as a 3-year average from the years 1989, 1990 and 1991 (for
the base year) and 2010, 2011 and 2012 (the final year). We calculated the number of deaths
from CHD that would have been expected in 2012 if the mortality rates in 1990 had remained
unchanged by multiplying the age-specific mortality rates for 1990 by the population for each
10-year age stratum in the year 2012. There were 10-year age and sex strata, from 25 to 84
years, plus two strata (one for men, one for women) above the age of 85. Population ageing
between 1990 and 2012 was taken into account by applying the age and sex specific rates from
1990 to the 2012 population by these strata. Subtracting the number of deaths observed in
2012 from the number expected based on the 1990 population then yielded the drop in the
number of deaths (prevented or postponed) in 2012 for the model to explain.
Sources of data for cardiovascular risk factors
In 1990, there was no single nationally representative survey which provided the range of data
needed for the model, thus data from the Global Burden of Disease (GBD) study were used.
The GBD estimates for 1990 were based on several national and community-based surveys
conducted in Barbados [20–22]. Risk factor data for 2012 were taken from a population based,
nationally representative survey conducted in 2012 and known as the Health of the Nation
(HotN)(18). Data on fruit and vegetable consumption and physical inactivity in 1990 were
Explaining coronary heart disease mortality trends in Barbados: 1990-2012
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unavailable from GBD. For these two items, we assumed that the 1990 values were the same as
those from the 2007 Barbados STEPS survey[23]. The limitations of this assumption are
acknowledged and addressed in sensitivity analyses.
CHD patients and uptake of cardiovascular-related treatments
From the Barbados National Registry for Chronic Non-communicable Disease (the BNR)[19],
we obtained acute myocardial infarction (AMI) incidence as well as MI hospital admissions
and case fatality rates for 2012 (S4 Table). Numbers of patients with unstable angina and heart
failure admitted to the island’s lone tertiary care public hospital (Queen Elizabeth Hospital
(QEH)) were obtained from the Ministry of Health.
We used data from the BNR for the years 2011–2014 to calculate the medication uptakes
within the first 24 hours as well as on discharge. Medications recorded were Aspirin, Angio-
tensin-Converting Enzyme (ACE) Inhibitors/Angiotensin Receptor Blockers (ARBs), Beta-
blockers, Thrombolytics and In-hospital Cardiopulmonary Resuscitation (S4 Table). Since
there was no published or raw data available to inform the treatment of heart failure and
angina in the hospital and the community, a retrospective chart review (n = 386) of patients
being treated during the years 2010 to 2014 was conducted at QEH and six of the twelve gov-
ernment-owned primary health care centres. The chart review provided data on the propor-
tions of angina and heart failure patients receiving medical and surgical treatments and
estimates of patients receiving Coronary Artery-Bypass Grafting (CABG) and Percutaneous
Coronary Intervention (PCI).
Qualitative methods used to inform the model
Documentary analysis was conducted by reviewing all Chief Medical Officer (CMO) Reports
and Barbados National Drug Formularies (BNDF) printed during the period 1988 to 2012.
The BNDF provided information on the availability of relevant drug categories such as beta-
blockers, aspirin, statins and ACE inhibitors in the public sector. The CMO reports provided
information on policy changes that may have affected availability of drugs and services such as
the policy of the Barbados Drug Service to make specific classes of drugs free at the point of
delivery to all residents of the country.
To obtain further information on the availability of major treatment interventions, such as
CABG, PCI, cardio-pulmonary resuscitation (CPR) and cardiac rehabilitation, semi-struc-
tured interviews were conducted. A purposive sample of eight health care professionals (cardi-
ologists, emergency physicians, family practitioners) operating in the island during the late
1980s and early 1990s was chosen. The life grid approach which has been used in epidemiolog-
ical studies involving dating and recall of temporally distant exposures[24–26], required that
participants remember what was occurring in their personal and professional lives in the year
1990. The interview guide can be found in S1 Appendix. Data from the interviews were ana-
lysed and in cases where there was significant disagreement amongst participants about a par-
ticular question, interviewees were asked to review their initial answer in the light of what has
been proposed by others. This attempt to reach consensus amongst experts is characteristic of
the Delphi process. A full explanation of the documentary analysis and semi-structured inter-
view methodology is available in S2 Appendix.
Estimating deaths prevented or postponed (DPPs) attributed to risk factors
Using the IMPACT model we estimated the number of DPPs related to changes in the preva-
lence of cardiovascular risk factors in the population. The risk factors considered were ciga-
rette smoking, total cholesterol, systolic blood pressure, body mass index, diabetes, physical
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inactivity and mean fruit and vegetable consumption per day. The number of DPPs from
changes in these risk factors was estimated using two approaches. For those risk factors mea-
sured as continuous variables (blood pressure, total cholesterol and BMI), the regression β
coefficients approach was used to quantify the population mortality impact. These β coeffi-
cients were obtained from international pooling studies (S2 Table). The DPPs as a result of the
change in the prevalence of or mean value for each of these risk factors was estimated as the
product of three variables: the number of deaths from CHD in 1990 (the initial year), the sub-
sequent reduction in that risk factor, and the regression coefficient (adjusted for confounders)
quantifying the change in mortality from CHD per unit of absolute change in the risk factor.
This calculation was repeated for each 10-year age-sex group.
The second approach, population-attributable risk fraction, was employed for categorical
variables—diabetes, physical inactivity and smoking using the equation below:
PAR ¼
Prevalence� ðRelative Risk   1Þ
ðPrevalence� ðRelative Risk   1ÞÞ þ 1
This PAR equation was repeated for each sex and age strata (10-year age groups 25–34, 35–
44 . . .. . . up to 85+). The relative risks used were adjusted for potential confounders.
Estimating the contributions of medical and surgical treatments
The mortality reduction for each treatment was calculated using the age-specific death rate in
each age and sex group multiplied by the relative mortality reduction reported in published
meta-analyses, multiplied by the treatment uptake (the proportion of patients receiving that
specific treatment).
In cases where a treatment was in use in 1990, the number of DPPs as a result of the therapy
used in 1990 was calculated and subtracted from the number of deaths for 2012 to calculate
the net benefit. Adjustments were made to account for poly-pharmacy using the Mant and
Hicks approach[27]. This approach assumes that for an individual receiving multiple interven-
tions, case fatality reduction is very unlikely to be additive and thus a cumulative relative bene-
fit is estimated. For blood pressure and cholesterol we separated the DPPs from
pharmacological versus non-pharmacological (lifestyle) changes by subtracting the DPPs cal-
culated in the treatment arm of the model from the DPPs calculated in the risk factor compo-
nent. The resulting DPPs were attributed to lifestyle changes.
Sensitivity analyses
This version of the IMPACT model uses the Excel add-in Ersatz software to perform a proba-
bilistic analysis around the estimates, using the parameter distributions in Appendices C and
D. Ersatz allows for repeatedly sampling (1000 iterations performed) random values from the
parameter distributions (S7 Table) for the input variables. The 95% uncertainty intervals for
the output variable (deaths prevented or postponed) are then calculated. We conducted alter-
native analyses replacing the GBD risk factor data (smoking, systolic blood pressure, body
mass index, diabetes and cholesterol) with data obtained from published articles of national
and sub-national population-based surveys conducted in Barbados (S3 Table) for 1990.
Finally, we used in a sensitivity analysis GBD risk factor estimates for both 1990 and 2012.
Ethics
Ethical approval was obtained from the Institutional Review Board of the University of the
West Indies; as well as the internal ethics committees of the Queen Elizabeth Hospital and the
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Ministry of Health (the government agency responsible for management of the public primary
care centres). All methods were performed in accordance with the relevant guidelines and reg-
ulations of all ethical boards identified. Written informed consent was obtained from partici-
pants as required.
Results
In 1990 the age-standardized CHD mortality rate was 109.5 per 100,000 per year, falling to
55.3 per 100,000 in 2012, a 46.1% decline in CHD deaths over this period (Table 1). This
resulted in 139 fewer deaths being observed in 2012 compared with the expected number had
the rates remained the same as in 1990. The model explained overall 75% (95% UI 59%, 96%)
of deaths prevented or postponed (DPPs). Approximately 56%, 95% UI (46%, 68%) of these
deaths were prevented because of the implementation of effective treatment for CHD while
the best estimate from the model indicated that decline in risk factors prevented 19% addi-
tional deaths 95% UI (6%, 34%).
Changes in major CHD risk factors
Age-adjusted risk factor improvements were noted with declines in total cholesterol (14.1%
and 12.7% relative decreases in men and women respectively); reduced mean systolic blood
pressure in women (1.3%); a reduction in physical inactivity in men(31.1%); and increases in
mean fruit and vegetable intake in both sexes (17.9% and 19.4% in men and women respec-
tively) (Table 2). However, the most impactful risk factor increase was the adverse trend in dia-
betes prevalence where rates increased by 6.5% in men and 41.5% in women (Table 2). Mean
Table 1. CHD mortality rates 1990 and 2012 by sex.
Male 1990 2012
Population (Over 25) (000s) 69 87
Observed CHD deaths 101 81
Age-standardized rate (00,000) 133.2 72.3
Expected deaths N/A� 144
Target DPPs N/A 63
% of expected deaths prevented N/A 43.8
Female 1990 2012
Population (Over 25) (000s) 81 99
Observed CHD deaths 120 81
Age-standardized rate (00,000) 90.6 41.9
Expected deaths N/A 157
Target DPPs N/A 76
% of expected deaths prevented N/A 48.0
Total 1990 2012
Population (Over 25) (000s) 149 183
Observed CHD deaths 221 162
Age-standardized rate (00,000) 109.5 55.3
Expected deaths N/A 301
Total DPPs N/A 139
% of expected deaths prevented N/A 46.1%
�N/A = Not applicable to this time period
https://doi.org/10.1371/journal.pone.0215392.t001
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BMI also increased in men and women by 5.3 and 6.6% respectively. Smoking prevalence rates
in Barbados in 1990 were relatively low (10.5% in men and 1.80% in women) and by 2012
rates were similar 11.1% and 2.3% in men and women respectively.
Table 2. Estimated absolute and relative age-adjusted changes in risk factor prevalence/mean levels occurring in Barbados from 1990 to 2012 comparing models 1
and 2.
Absolute level
of risk factor
Change in risk factord Changes in risk factors–Model 2
Population risk factor 1990 2012c Absolute risk reduction (ARR) Relative risk reduction (%) Absolute risk reduction
ARR)
Relative risk reduction (RRR)
Prevalence of smoking (%)a
Men 10.5 11.1 0.6 18.1% 0.003 2.5%
Women 1.8 2.3 0.5 21.7% 0.001 3.5%
Systolic Blood pressure (mmHg)(anti-hypertensive treatment effects subtracted)a
Men 132.3 132.7 0.4 0.4% 0.1 0.1%
Women 130.7 128.6 -2.1 -1.3% -1.2 -0.9%
Total cholesterol (mmol/l) statin effects subtracteda
Men 5.0 4.2 -0.8 -14.1% -0.3 -4.8%
Women 5.2 4.4 -0.8 -12.7% -0.2 -3.2%
Physical inactivity (%) (Base year-2007)b
Men 43.0 31.0 -12.0 -31.1% -12.0 -31.1%
Women 59.3 67.2 7.9 15.1% 7.9 15.1%
Body Mass Index a
Men 25.2 26.6 1.4 5.3% 1.5 5.9%
Women 27.8 29.7 1.8 6.6% 1.9 6.8%
Prevalence of diabetesa
Men 12.4 16.3 3.9 6.5% 0.01 11.4%
Women 13.1 21.6 8.5 41.5% 0.04 35.9%
Mean Fruit and Vegetables/day (Base year– 2007)b
Men 1.9 2.2 0.3 17.9% 0.3 17.9%
Women 2.0 2.4 0.4 19.4% 0.4 19.4%
a Data for base year obtained from Global Burden of Disease records.
b Data for base year obtained from Barbados STEP Risk Factor Survey 2007.
c Data for 2012 obtained from Health of the Nation Survey in all cases
d Decreases in risk factor levels denoted by a “–” sign.
https://doi.org/10.1371/journal.pone.0215392.t002
Table 3. Estimated numbers of deaths from coronary heart disease prevented or postponed by medical and surgical treatments in Barbados in 2012.
M&H� Net DPPs
Best estimate(95% UI)
% of total DPPs
Best estimate(95% UI)
INITIAL TREATMENTS FOR ACUTE MI 18.4(15.4,21.7) 13.3%(10.4,17.0)
UNSTABLE ANGINA 12.7(10.1,15.8) 9.2%(6.9,12.0)
SECONDARY PREVENTION FOLLOWING AMI 11.9(9.8,14.5) 8.6%(6.7,11.0)
SECONDARY PREVENTION FOLLOWING CABG/PCI 0.2(0.2,0.3) 0.2%(0.1,0.2)
ANGINA IN THE COMMUNITY 3.8(2.9,4.8) 2.8%(2.0,3.7)
HEART FAILURE IN THE HOSPITAL 6.4(4.8,8.2) 4.6%(3.4,6.2)
HEART FAILURE IN THE COMMUNITY 6.1(4.7,6.8) 4.1%(3.2,5.2)
STATINS FOR PRIMARY PREVENTION 6.2(4.7,8.0) 4.5%(3.3,6.1)
ANTIHYPERTENSIVE MEDICATION 12.1(6.0,18.1) 8.8%(4.6,13.2)
�M&H–Mant and Hicks
https://doi.org/10.1371/journal.pone.0215392.t003
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Deaths prevented or postponed from medical and surgical treatments
Medical and surgical treatments together prevented/postponed approximately 78 deaths 95%
UI(69, 86) in 2012. Improvements in the initial treatments of acute myocardial infarction
accounted for the most deaths prevented by an in-hospital treatment modality, 13% (10%,
17%) of the DPPs (Table 3). Antihypertensive treatment in the primary care was also effective,
accounting for 9% (7%,11%) of DPPs, while statin treatment accounted for 5% (3%,6%) DPPs.
The impact of secondary prevention after AMI was also relatively modest due to the high case-
fatality rates following AMI in Barbados[28]- secondary prevention following AMI accounted
for 8.6% of DPPs 95% UI (6.7,11.0). The unavailability of Primary PCI in the public sector dur-
ing the time period and limited availability of coronary artery-bypass grafting resulted in no
deaths prevented via secondary prevention after these interventions (S5 & S6 Tables).
Deaths prevented or postponed from changes in risk factors
Risk factor improvements in total cholesterol levels, systolic blood pressure, fruit and vegetable
consumption and physical inactivity accounted for the postponement of 52 deaths, but wors-
ening trends in other risk factors (smoking, diabetes and obesity) were responsible for an addi-
tional 26 deaths in 2012, resulting in an overall risk factor effect of 26 DPPs (95% UI 8, 45).
Approximately 25% of deaths remained unexplained. Cholesterol declines were the most posi-
tively impactful risk factor resulting in 28% (21%, 37%) of DPPs; most of which (22%) were
attributed to lifestyle changes.
Fig 1 summarises the DPPs or additional deaths from each treatment and risk factor trend,
with the bars representing lower and upper uncertainty intervals generated from the probabi-
listic analysis. In the overall population systolic blood pressure accounted for 24% of DPPs; 9%
as a result of improved coverage of anti-hypertensive therapy (Table 3) and 15% as a result of
secular trends.
Sensitivity analyses
Sensitivity analyses were conducted using Global Burden of Disease risk factor data for both
1990 and 2012. In this alternative model the total model fit was reduced to 49% (34.0%, 66%),
with the difference mainly due to varying estimates of the change of systolic blood pressure,
total cholesterol and diabetes prevalence. Broadly, the contribution of cholesterol to CHD
mortality reduction was reduced (Table 2).
Discussion
Using the IMPACT model for the small island developing state of Barbados, we found that
56% of the decline in CHD mortality was due to the introduction or improved uptakes of effec-
tive treatments while 19% was due to underlying change in risk factors. The highest percent-
ages of DPPs were for treatments given in the first 24 hours for myocardial infarction and for
treatment of hypertension and high cholesterol in primary care. Given the small size of the
population the uncertainty intervals around our point estimates were wide; the lower and
upper uncertainty intervals for the main model fit were 60% and 96% respectively and results
must be interpreted accordingly.
Risk factor changes
The most important risk factor change contributing to the decline in CHD deaths was the high
proportion of deaths postponed because of changes in mean cholesterol levels in the popula-
tion. We estimated that only one third of this reduction was attributed to the introduction of
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statins. It is possible that dietary changes could explain some of the decline in mean cholesterol
levels, but we may also have underestimated the use of statins in our retrospective chart review.
Chart reviews often underestimate treatments given since health care providers may have less
than stellar documentation practices and handwriting may be difficult for abstractors to deci-
pher despite training. A small study by Sheehy et al suggested that even though energy from fat
intake increased from 1961 to 2003 the contribution of saturated fats to total energy decreased
over this time period[29]. Most of this decrease appeared to have occurred in the decade of the
eighties with no real change noted from 1990 until the end of the study in 2003 [29].
The very low contribution of risk factor reductions to the decline of CHD should be of sig-
nificant concern to policy makers in Barbados. It demonstrates an opportunity for all of society
in a “Health in all Policies[30]” approach to implement population wide programs to change
the current tide of rapidly increasing risk factors. Truly upstream approaches must be the pri-
ority so that the declines in mean systolic blood pressure or cholesterol or glucose levels will
not be driven by medication but rather by lifestyle changes.
There has been some effort made at the local and regional level in the Caribbean to reduce
the chronic disease risk factor burden. At the regional level the Port of Spain NCD declaration
in 2007 and globally the 2011 UN High Level Meeting represent political leadership and com-
mitment to the reduction of NCD risk, morbidity and mortality. The impact that these declara-
tions have had on risk factor burden is unclear and the initial results of a study to evaluate the
outcomes has shown that “NCDs are not given the political priority that is thought to be
required to reduce the burden[31]”.
Caribbean countries have reportedly had similar trends in risk factors [32] across the region
but varying coronary heart disease mortality outcomes[33], suggesting some variations in the
prevention strategies and management of the risk factors and/or outcomes. These variations
Fig 1. Percentage deaths prevented or postponed for several treatment groups and major cardiovascular risk factors in Barbados from
1990 to 2012.
https://doi.org/10.1371/journal.pone.0215392.g001
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may be due to a combination of health care system structure and the policy environment. The
fact that most of the decline in CHD mortality in Barbados was due to treatment provides an
example for SIDs about the advantages of universal access to care and treatment.
Treatment approaches
Barbados, during the time period of this analysis began to offer fibrinolytic treatment for
reperfusion but does not yet provide primary percutaneous intervention (PCI) for acute myo-
cardial infarction routinely. PCI has been associated with lower mortality rates than fibrino-
lytic therapy but this is true in settings where there is a sufficiently high volume of cardiac
events and the staffing required for 24-hour coverage of the catheterization laboratory[34, 35].
Further work is needed to explore the potential impact of introducing PCI versus focusing on
increasing uptake of fibrinolytic therapy given the number of STEMI cases seen in this gener-
ally low resource setting.
Model fit
The overall model fit (75%) was similar to Finland, Turkey and Palestine (76%, 77% and 78%
respectively (Fig 2), although the uncertainty intervals suggest it could be as much as 96%. In
most other countries where the IMPACT model has been used, risk factor changes have made
larger contributions to the declines noted in CHD[7, 9, 10]. Smoking was one of the major risk
factors whose rates declined dramatically in other countries and thus was a major risk factor
contributor to CHD declines[36]. In Barbados, smoking rates were recorded as relatively low
in the 1990s. Thus its contribution to the decline in deaths in 2012 was understandably low.
Our use of a qualitative study to inform our assumptions about study estimates in the base
year represents one of the strengths of our study, providing contextual information around the
progression of myocardial infarction management in the island.
We explored the uncertainty in the data by using rates and mean values estimated from the
Global Burden of Disease project for both time periods but found that risk factors explained
only a small proportion of the decline noted in CHD mortality. The fact that the relative risks
being used in the model were adapted from international sources, may have underestimated
the strength of association between diabetes or BMI and antihypertensive use and CHD risk in
this Afro-Caribbean population. Individual relative risk associations have been found to be dif-
ferent by ethnicity[37]. We accounted for this difference by ethnicity by using relative risks for
diabetes that were specific to an African population[38] but were unable to do this for the
other risk factors.
Limitations
Since our treatment coverage data were taken from patients notes where there may be under-
reporting of medications prescribed, we may be underestimating the effects of treatments on
CHD mortality decline. There was a lack of quality data on fruit and vegetable intake and phys-
ical inactivity levels for the earlier time period but given our findings of 1–2% contribution to
DPPs it seems likely that the even with the most extreme sensitivity analyses plausible the
impact of changes in these risk factors would be small. It is also possible that improvements in
CHD mortality coding over time could be resulting in an over-estimate of the decline in CHD
mortality in Barbados[39]. Data from the Pan American Health Organization suggests that
mortality coding quality has improved in Caribbean countries over the time period being stud-
ied[40].
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Conclusion
We found that CHD mortality rates declined by approximately 46.1% in Barbados from 1990
to 2012. Approximately 56% of this decline can be attributed to the introduction and increased
uptake of medical treatments, mostly drug therapies used in the first 24 hours after AMI as
well as statins and anti-hypertensives prescribed in primary care. It is imperative that future
research explores the feasibility and cost-effectiveness of introducing primary PCI as well as
increasing uptake of medical treatments (including fibrinolysis) for CHD. Given the signifi-
cant negative impact of obesity/diabetes on mortality in this analysis, research that explores
factors affecting implementation of evidenced-based preventive strategies (e.g. increased phys-
ical activity, elimination of dietary trans-fats) to reduce diabetes and obesity is desperately
needed. Exploring the reasons for these trends in other SIDs could facilitate quantifying the
impact of universal access to care on CHD trends.
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